MLC-2 Polyclonal Antibody

MYL12A encodes a nonsarcomeric myosin regulatory light chain. Myosin regulatory light chain 12A is activated by phosphorylation and regulates smooth muscle and non-muscle cell contraction. This protein may also be involved in DNA damage repair by sequestering the transcriptional regulator apoptosis-antagonizing transcription factor (AATF)/Che-1 which functions as a repressor of p53-driven apoptosis. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 8.

The MLC-2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of myosin light chain 2 (MLC-2) protein in various biological samples. This antibody is produced using a polyclonal approach, ensuring a diverse range of epitope recognition and enhanced sensitivity.

The MLC-2 Polyclonal Antibody exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been rigorously validated to provide reliable and reproducible results, making it an ideal choice for both research and diagnostic purposes.

With its high affinity and specificity towards MLC-2, this antibody enables accurate and precise detection of this crucial protein in various tissues and cell types. Its exceptional sensitivity allows for the detection of even low abundance MLC-2, ensuring accurate quantification and analysis.

The MLC-2 Polyclonal Antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to ensure batch-to-batch consistency and reliability. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation.

In summary, the MLC-2 Polyclonal Antibody is a highly reliable and sensitive tool for the detection and quantification of MLC-2 protein. Its exceptional performance, versatility, and ease of use make it an indispensable asset for researchers and clinicians alike.